Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 23. March 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9326  Previews Next
   
   Articles 1 - 20 / 186510  
   
Gold Nanoparticles in Bladder Cancer Applications: A Paradigm Shift from Diagnostic Tools to Integrated Theranostic Platforms.
Int J Nanomedicine
Zhang X, Wu X, Du J, Mei J, Chen F, Lou K.
PMID: 41869400 [PubMed - as supplied by publisher]


Cause-specific mortality beyond prostate cancer in young men: a population-based study of second malignancies and non-tumor causes.
Am J Transl Res
Kang Y, Liu J, Lin Y, Pang L.
PMID: 41868909 [PubMed - as supplied by publisher]


Identification of risk factors for the development and prognosis of bone metastases in renal cell carcinoma: development and validation of a predictive model.
Am J Cancer Res
Zeng W, Wu Z, Sun Y, Ma M, Fan A, Liu Z, Luo S.
PMID: 41868662 [PubMed - as supplied by publisher]


Phellinus linteus polysaccharides inhibit castration-resistant prostate cancer progression possibly via dual modulation of PIK3R1 and PGC-1α: a preclinical evaluation.
Am J Cancer Res
Wei W, Huang J, Xie L, Xu Z, Lin C, Chen M.
PMID: 41868659 [PubMed - as supplied by publisher]


Research progress on the intrinsic link between the occurrence and progression of malignant tumors, chronic kidney disease and drug safety.
Am J Cancer Res
Zhang D, Jiang S, Liu L, Lu J, Li W.
PMID: 41868657 [PubMed - as supplied by publisher]


Diagnostic Value of Multiparametric Transrectal Ultrasound in Patients with Suspected Carcinoma of Prostate: A Tertiary Care Centre Experience.
Indian J Radiol Imaging
Chowhan PS, Gorsi U, Mavuduru R, Lal A, Mete UK, Kakkar N.
PMID: 41867289 [PubMed]


NICE 2026 guideline for the diagnosis and management of kidney cancer.
Lancet Oncol
Stewart GD, Boyce S, Harrisingh MC, Crane O, NICE Kidney Cancer Guideline Committee Members.
PMID: 41865753 [PubMed - as supplied by publisher]


DaBlaCa-13 Study: Five-year Follow-up from the Randomized Controlled Trial of Chemoresection with Intravesical Mitomycin C in Recurrent Ta Non-muscle-invasive Bladder Cancer.
Eur Urol Oncol
Klingenberg S, Lindgren MS, Jakobsen JK, Jensen JB, Kingo PS.
PMID: 41864769 [PubMed - as supplied by publisher]


Re: Hiroshi Kitamura, Taiji Tsukamoto, Yoshiyuki Kakehi, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.008.
Eur Urol
Contieri R, Lazzeri M, Perdonà S, Hurle R.
PMID: 41864760 [PubMed - as supplied by publisher]


Reply to Roberto Contieri, Massimo Lazzeri, Sisto Perdonà, and Rodolfo Hurle's Letter to the Editor re: Kitamura, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008.
Eur Urol
Kitamura H, Nishiyama H.
PMID: 41864759 [PubMed - as supplied by publisher]


Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study.
Int J Radiat Oncol Biol Phys
Anger E, Supiot S, Josset Q, Pasquier D, Vaugier L, Riet FG, Pointreau Y, Ruffier A, Loos G, Terlizzi M, Blanchard P, Martin E, Sargos P, Guerni M, Schick U, Bera G, Roman J, Latorzeff I, Créhange G, Castelli J, Barateau A, De Crevoisier R, Nicosia L, Guévelou JL.
PMID: 41864432 [PubMed - as supplied by publisher]


Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study.
J Am Acad Dermatol
Chen YJ, Liu WT, Yang CC.
PMID: 41864295 [PubMed - as supplied by publisher]


Editorial Comment on "A Practical Phenotyping Framework for Male LUTS Using Remote Multi-Day Urinary Diagnostics".
Urology
Te AE.
PMID: 41864286 [PubMed - as supplied by publisher]


Endothelial SMAD1-MCAM axis facilitates sunitinib resistance and progression of clear cell renal cell carcinoma via LAMB1-ITGB1 signaling.
Drug Resist Updat
Zhang H, Liu Y, Zhang W, Guo Y, Lin A, Jin Y, Lu P, Fang Y, Zhang H, Qu L, Luo P, Wu L, Chen Y, Kang X, Wang L, Jiang A.
PMID: 41864072 [PubMed - as supplied by publisher]


Hematuria-related readmission after transurethral resection of bladder tumor in patients receiving antiplatelet therapy.
Urologia
Ilktac A, Dogan B, Gevher F, Akcay M, Akbulut H, Ilbey YO.
PMID: 41863856 [PubMed - as supplied by publisher]


Surgical Management of Bone Metastases in Bladder Cancer: A Single-Center Retrospective Study.
Cancer Rep (Hoboken)
Doumanidis P, Tsagkozis P.
PMID: 41863065 [PubMed - indexed for MEDLINE]


PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial.
Trials
Johnson D, Thomas R, Cotton S, Newlands R, Cooper D, McCann S, Vale L, Gillies K, Bex A, Challacombe B, Falloon J, MacLennan G, Narahari K, Nicol D, Sheerin N, Stewart GD, Tran M, Heer R, Soomro N.
PMID: 41863008 [PubMed - as supplied by publisher]


Association between presurgical physical activity and urinary and sexual function in prostate cancer patients treated by radical prostatectomy: A prospective cohort study.
Urol Oncol
Harper A, Khan M, Imm KR, Grubb RL 3rd, Kim EH, Colditz GA, Wolin KY, Kibel AS, Sutcliffe S, Yang L.
PMID: 41862406 [PubMed - as supplied by publisher]


Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical Perspective.
Eur Urol Oncol
Duquesne I, Epelbaum I, Prost D, Haberstich M, Suartz CV, Blons H, Taly V, Laurent-Puig P, Horowitz A, Sfakianos JP, Thibault C, Audenet F.
PMID: 41862336 [PubMed - as supplied by publisher]


Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14).
Eur Urol Oncol
Gillessen S, Gobat K, Cathomas R, Fischer N, Pereira Mestre R, Hermanns T, Rothschild SI, Mach N, Mingrone W, Ciriolo M, Müller B, Erdmann A, Schär C, Mamot C, Bohanes P, Omlin A, Bastian S, Ribi K, Mazzucchelli L, Barizzi J, Horvath LG, Scheinberg T, Mellor R, Schär S, Lin HM, Lim R, Pollak M, Turco F, Rothermundt C.
PMID: 41862335 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 186510    Page 1 of 9326  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1